Not applicableStudy completedNCT00899912What this trial is testingChanges in DNA After Radiation Therapy in Patients With Prostate CancerWho this might be right forProstate Cancer Radiation Therapy Oncology Group 13
Not applicableStudy completedNCT00052481What this trial is testingQuality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate CancerWho this might be right forProstate Cancer Alliance for Clinical Trials in Oncology 500
Testing effectiveness (Phase 2)Study completedNCT00071968What this trial is testingNeoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of RelapseWho this might be right forProstate Cancer Jonsson Comprehensive Cancer Center 15
Not applicableStudy completedNCT00685516What this trial is testingGreen Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing SurgeryWho this might be right forProstate Cancer Jonsson Comprehensive Cancer Center 113
Testing effectiveness (Phase 2)Study completedNCT00714753What this trial is testingInternal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate CancerWho this might be right forProstate Cancer Mayo Clinic 5
Testing effectiveness (Phase 2)Study completedNCT00040755What this trial is testingBMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyWho this might be right forAdenocarcinoma of the ProstateBone MetastasesHormone-resistant Prostate Cancer+2 more National Cancer Institute (NCI) 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT02949284What this trial is testingAndrogen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing SurgeryWho this might be right forStage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma Rutgers, The State University of New Jersey 90
Testing effectiveness (Phase 2)WithdrawnNCT00598858What this trial is testingNeoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the ProstateWho this might be right forProstate CancerAdenocarcinoma of the ProstateStage I Prostate Cancer+1 more John P. Fruehauf
Large-scale testing (Phase 3)Study completedNCT00541047What this trial is testingRADICALS - Radiotherapy and Androgen Deprivation In Combination After Local SurgeryWho this might be right forGastrointestinal ComplicationsProstate CancerSexual Dysfunction+1 more University College, London 4,236
Testing effectiveness (Phase 2)Looking for participantsNCT06173362What this trial is testingAbiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate CancerWho this might be right forAdvanced Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IV Prostate Cancer AJCC v8 University of California, Davis 75
Testing effectiveness (Phase 2)Study completedNCT00022399What this trial is testingCelecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate CancerWho this might be right forProstate Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 73
Testing effectiveness (Phase 2)Active Not RecruitingNCT02713269What this trial is testingThermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal CordWho this might be right forMalignant Digestive System NeoplasmMetastatic Head and Neck CarcinomaMetastatic Kidney Carcinoma+10 more M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT00225420What this trial is testingDocetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate CancerWho this might be right forProstate Cancer UNC Lineberger Comprehensive Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT03113617What this trial is testing68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate CancerWho this might be right forStage II Prostate AdenocarcinomaStage III Prostate AdenocarcinomaStage IV Prostate Adenocarcinoma Andrei Iagaru 44
Large-scale testing (Phase 3)Active Not RecruitingNCT03070886What this trial is testingAntiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by SurgeryWho this might be right forStage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7Stage III Prostate Adenocarcinoma AJCC v7 NRG Oncology 612
Large-scale testing (Phase 3)Study completedNCT01272050What this trial is testingRadiation Therapy in Treating Patients With Relapsed Prostate Cancer After SurgeryWho this might be right forProstate Cancer Swiss Cancer Institute 350
Early research (Phase 1)Study completedNCT02048150What this trial is testingIntra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate CancerWho this might be right forAdenocarcinoma of the ProstateStage IIB Prostate CancerStage III Prostate Cancer+1 more City of Hope Medical Center 7
Testing effectiveness (Phase 2)Study completedNCT01832259What this trial is testingVEGF Tyrosine Kinase Inhibitor (Pazopanib) in Men With High-Risk Prostate Cancer Followed by Radical Prostatectomy and Pelvic Lymph Node DissectionWho this might be right forAdenocarcinoma of the Prostate University of Utah 30
Testing effectiveness (Phase 2)Study completedNCT00003394What this trial is testingCombination Chemotherapy in Treating Patients With Advanced Prostate CancerWho this might be right forProstate Cancer Memorial Sloan Kettering Cancer Center 18
Not applicableStudy completedNCT00706966What this trial is testingMRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate CancerWho this might be right forNonmalignant NeoplasmProstate Cancer University of California, San Francisco 10